Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beisel, K.W., David, C.S., Giraldo, A.A., Kong, Y.M., and Rose, N.R. (1982). Regulation of experimental autoimmune thyroiditis: Mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics, 15, 427–431.
Cannons, J.L., Lau, P., Ghumman, B., Debenedette, M.A., Yagita, H., Okumura, K., and Watts, T.H. (2001). 4-1bb ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol., 167, 1313–1324.
Caspi, R.R. (1998). IL-12 in autoimmunity. Clin. Immunol. Immunopathol., 88, 4–13.
Dinarello, C.A. (1989). Interleukin-1 and its biologically related cytokines. Adv. Immunol., 44, 153–205.
Elrehewy, M., Kong, Y.M., Giraldo, A.A., and Rose, N.R. (1981). Syngeneic thyroglobulin is immunogenic in good responder mice. Eur. J. Immunol., 11, 146–151.
Fuller, B.E., Okayasu, I., Simon, L.L., Giraldo, A.A., and Kong, Y.M. (1993). Characterization of resistance to murine experimental autoimmune thyroiditis: Duration and afferent action of thyroglobulin-and TSH-induced suppression. Clin. Immunol. Immunopathol., 69, 60–68.
Germann, T., Szeliga, J., Hess, H., Störkel, S., Podlaski, F.J., Gately, M.K., Schmitt, E., and Rüde, E. (1995). Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA, 92, 4823–4827.
Kong, Y.M. (1999). In R. Volpe (ed.), Contemporary Endocrinology: Autoimmune Endocrinopathies. Humana Press, Totowa, New Jersey. pp. 91–111.
Kong, Y.M. and David, C.S. (2000). New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int. Rev. Immunol., 19, 573–585.
Kong, Y.M., David, C.S., Lomo, L.C., Fuller, B.E., Motte, R.W., and Giraldo, A.A. (1997). Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics, 46, 312–317.
Kong, Y.M., Flynn, J.C., Wan, Q., and David, C.S. (2003). HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity, 36, 397–404.
Kong, Y.M., Giraldo, A.A., Waldmann, H., Cobbold, S.P., and Fuller, B.E. (1989). Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin. Immunol. Immunopathol., 51, 38–54.
Kong, Y.M., Lomo, L.C., Motte, R.W., Graldo, A.A., Baisch, J., Strauss, G., Hämmerling, G.J., and David, C.S. (1996). HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: Definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med., 184, 1167–1172.
Kong, Y.M., Okayasu, I., Giraldo, A.A., Beisel, K.W., Sundick, R.S., Rose, N.R., David, C.S., Audibert, F., and Chedid, L. (1982). Tolerance to thyroglobulin by activating suppressor mechanisms. Ann. NY Acad. Sci., 392, 191–209.
Leonard, J.P., Waldburger, K.E., Schaub, R.G., Smith, T., Hewson, A.K., Cuzner, M.L., and Goldman, S.J. (1997). Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit. Rev. Immunol., 17, 545–553.
Lewis, M., Fuller, B.E., Giraldo, A.A., and Kong, Y.M. (1992). Resistance to experimental autoimmune thyroiditis is correlated with the duration of raised thyroglobulin levels. Clin. Immunol. Immunopathol., 64, 197–204.
Lewis, M., Giraldo, A.A., and Kong, Y.M. (1987). Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level. Clin. Immunol. Immunopathol., 45, 92–104.
McHugh, R.S. and Shevach, E.M. (2002). Cutting edge: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol., 168, 5979–5983.
Melero, I., Johnston, J.V., Shufford, W.W., Mittler, R.S., and Chen, L. (1998). NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol., 190, 167–172.
Mignon-Godefroy, K., Brazillet, M.P., Rott, O., and Charreire, J. (1995). Distinctive modulation by IL-4 And IL-10 of the effector function of murine thyroglobulin-primed cells in “transferexperimental autoimmune thyroiditis.” Cell. Immunol., 162, 171–177.
Morris, G.P., Chen, L., and Kong, Y.M. (2003). CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol., 226, 20–29.
Morris, G.P. and Kong, Y.M. (2004). Naturally-existing CD4+CD25+ regulatory T cells: A peripheral barrier to autoimmune thyroiditis. Turkish J. Endocrinol. Metab. 8(Suppl. 1):28.
Morris, G.P., Yan, Y., David, C.S., and Kong, Y.M. (2004). CD4+CD25+ regulatory T cells modulate autoimmune thyroiditis, but do not supersede MHC class II restriction in the novel H2a−E+ transgenic model. Clin. Invest. Med., 27, 93b.
Nabozny, G.H. and Kong, Y.M. (1992). Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1β. J. Immunol., 149, 1086–1092.
Pennline, K.J., Roque-Gaffney, E., and Monahan, M. (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol., 71, 169–175.
Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M., and Rocken, M. (1994). Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med., 180, 1961–1966.
Rapoport, M.J., Jaramillo, A., Zipris, D., Lazarus, A.H., Serreze, D.V., Leiter, E.H., Cyopick, P., Danska, J.S., and Delovitch, T.L. (1993). Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87–99.
Rott, O., Fleischer, B., and Cash, E. (1994). Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol., 24, 1434–1440.
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor A-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151–1164.
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. (2002). Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol., 3, 135–142.
Staruch, M.J. and Wood, D.D. (1983). The adjuvanticity of interleukin 1 in vivo. J. Immunol., 130, 2191–2194.
Sun, Y., Lin, X., Chen, H.M., Wu, Q., Subudhi, S.K., Chen, L., and Fu, Y.-X. (2002). Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J. Immunol., 168, 1457–1465.
Thornton, A.M. and Shevach, E.M. (2000). Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol., 164, 183–190.
Tone, M., Tone, Y., Adams, E., Yates, S.F., Frewin, M.R., Cobbold, S.P., and Waldmann, H. (2003). Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA, 100, 15059–15064.
Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K., and Adorini, L. (1995). Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817–821.
Vladutiu, A.O. and Rose, N.R. (1971). Autoimmune murine thyroiditis: Relation to histocompatibility (H-2) type. Science, 174, 1137–1139.
Wan, Q., Shah, R., Mccormick, D.J., Lomo, L.C., Giraldo, A.A., David, C.S., and Kong, Y.M. (1999). H2-E transgenic class II-negative mice can distinguish self from nonself in susceptibility to heterologous thyroglobulins in autoimmune thyroiditis. Immunogenetics, 50, 22–30.
Wan, Q., Shah, R., Panos, J.C., Giraldo, A.A., David, C.S., and Kong, Y.M. (2002). HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum. Immunol., 63, 301–310.
Wei, W.-Z., Morris, G.P., and Kong, Y.M. (2004). Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells. Cancer Immunol. Immunother., 53, 73–78.
Zhang, W., Flynn, J.C., and Kong, Y.M. (2001). IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: Role of IFN-γ and the costimulatory molecules CD40L and CD28. Cell. Immunol., 208, 52–61.
Zhang, W. and Kong, Y.M. (1998). Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cell. Immunol., 187, 95–102.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Kong, Yc.M., Morris, G.P., David, C.S. (2005). Extent of Regulatory T Cell Influence on Major Histocompatibility Complex Class II Gene Control of Susceptibility in Murine Autoimmune Thyroiditis. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_15
Download citation
DOI: https://doi.org/10.1007/0-387-24534-0_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24533-1
Online ISBN: 978-0-387-24534-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)